Capital market regulator Sebi on Monday allowed Fresenius Kabi Oncology to delist its shares from the Indian stock market and asked the healthcare firm to complete the delisting process within three months -- bringing to an end a long-standing dispute.
first published: Jul 22, 2013 11:00 pm
A collection of the most-viewed Moneycontrol videos.
Nifty At Over 3-Month Low; Will The Bulls Make A Comeback?| Opening Bell Live
Small town, Big tech: Sridhar Vembu on Zoho’s rural push, AI Bubble, SaaS consolidation & many more
Live: DAVOS 2026 Day 5 Highlights: Elon Musk, AI Innovations & India’s Investment Pitch
Budget 2026 Decoded ? Key Terms You Must Know | Inflation, Taxes & Spending
